Copyright
©The Author(s) 2023.
World J Psychiatry. Aug 19, 2023; 13(8): 511-523
Published online Aug 19, 2023. doi: 10.5498/wjp.v13.i8.511
Published online Aug 19, 2023. doi: 10.5498/wjp.v13.i8.511
Figure 4 Comparison of iron death-related protein levels in hippocampal neurons of mice in the different treatment groups.
A: Expression levels of p-mammalian target of rapamycin, SLC7A11, glutathione peroxidase 4, and transferrin receptor 1 were detected by western blot; B-E: The relevant data. aP < 0.05, compared with the blank group; bP < 0.05, compared with the amyloid β group; cP < 0.05, compared with the dexmedetomidine group. Aβ: Amyloid β; Dex: Dexmedetomidine; si-mTOR: Mammalian target of rapamycin siRNA; GPX4: Glutathione peroxidase 4; TFR1: Transferrin receptor 1.
- Citation: Qiao L, Li G, Yuan HX. Dexmedetomidine mediates the mechanism of action of ferroptosis in mice with Alzheimer’s disease by regulating the mTOR-TFR1 pathway. World J Psychiatry 2023; 13(8): 511-523
- URL: https://www.wjgnet.com/2220-3206/full/v13/i8/511.htm
- DOI: https://dx.doi.org/10.5498/wjp.v13.i8.511